patient_id,trial_name,eligibility_label,explanation,natural_language_profile
ASCE_0001,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0002,ASCENT-05,Eligible,Eligible despite minor inclusion gaps: Organ function is adequate set to No. No exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: No
BMI over 30: No"
ASCE_0003,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: No
BMI over 30: Yes"
ASCE_0004,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0005,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: No
BMI over 30: Yes"
ASCE_0006,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: No"
ASCE_0007,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: No
BMI over 30: Yes"
ASCE_0008,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0009,ASCENT-05,Eligible,Eligible despite minor inclusion gaps: Patient is over 18 set to No. No exclusion criteria violated.,"Patient is over 18: No
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: No
BMI over 30: No"
ASCE_0010,ASCENT-05,Eligible,Eligible despite minor inclusion gaps: Has received radiotherapy set to No. No exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0011,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0012,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: No
BMI over 30: Yes"
ASCE_0013,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: No
BMI over 30: Yes"
ASCE_0014,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: No"
ASCE_0015,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: No
BMI over 30: Yes"
ASCE_0016,ASCENT-05,Eligible,Eligible despite minor inclusion gaps: Organ function is adequate set to No. No exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: No
BMI over 30: Yes"
ASCE_0017,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: No
BMI over 30: Yes"
ASCE_0018,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: No
BMI over 30: Yes"
ASCE_0019,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: No
BMI over 30: Yes"
ASCE_0020,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: No
BMI over 30: Yes"
ASCE_0021,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0022,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: No
BMI over 30: Yes"
ASCE_0023,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0024,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0025,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: No
BMI over 30: Yes"
ASCE_0026,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: No"
ASCE_0027,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: No
BMI over 30: No"
ASCE_0028,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: No"
ASCE_0029,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: No
BMI over 30: Yes"
ASCE_0030,ASCENT-05,Eligible,Eligible despite minor inclusion gaps: Patient is over 18 set to No. No exclusion criteria violated.,"Patient is over 18: No
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0031,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0032,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0033,ASCENT-05,Eligible,Eligible despite minor inclusion gaps: ECOG performance status is 0 or 1 set to No. No exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: No
BMI over 30: No"
ASCE_0034,ASCENT-05,Eligible,Eligible despite minor inclusion gaps: Patient is over 18 set to No. No exclusion criteria violated.,"Patient is over 18: No
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0035,ASCENT-05,Eligible,Eligible despite minor inclusion gaps: Patient is over 18 set to No. No exclusion criteria violated.,"Patient is over 18: No
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0036,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: No
BMI over 30: Yes"
ASCE_0037,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: No
BMI over 30: Yes"
ASCE_0038,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: No
BMI over 30: No"
ASCE_0039,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: No"
ASCE_0040,ASCENT-05,Eligible,"Eligible despite minor inclusion gaps: Organ function is adequate, Has received radiotherapy set to No. No exclusion criteria violated.","Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: No"
ASCE_0041,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0042,ASCENT-05,Eligible,Eligible despite minor inclusion gaps: ECOG performance status is 0 or 1 set to No. No exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0043,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: No"
ASCE_0044,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: No
BMI over 30: Yes"
ASCE_0045,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: No"
ASCE_0046,ASCENT-05,Eligible,Eligible despite minor inclusion gaps: Patient is over 18 set to No. No exclusion criteria violated.,"Patient is over 18: No
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0047,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0048,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0049,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: No
BMI over 30: No"
ASCE_0050,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: No
BMI over 30: No"
ASCE_0051,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0052,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: No"
ASCE_0053,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: No
BMI over 30: Yes"
ASCE_0054,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: No
BMI over 30: Yes"
ASCE_0055,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0056,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: No"
ASCE_0057,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0058,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0059,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: No
BMI over 30: No"
ASCE_0060,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0061,ASCENT-05,Eligible,Eligible despite minor inclusion gaps: Has received radiotherapy set to No. No exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: No
BMI over 30: No"
ASCE_0062,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: No
BMI over 30: Yes"
ASCE_0063,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: No
BMI over 30: No"
ASCE_0064,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: No
BMI over 30: Yes"
ASCE_0065,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0066,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0067,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: No
BMI over 30: No"
ASCE_0068,ASCENT-05,Eligible,Eligible despite minor inclusion gaps: Organ function is adequate set to No. No exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0069,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0070,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: No
BMI over 30: Yes"
ASCE_0071,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0072,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0073,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: No"
ASCE_0074,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0075,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0076,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: No
BMI over 30: Yes"
ASCE_0077,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: No
BMI over 30: No"
ASCE_0078,ASCENT-05,Eligible,Eligible despite minor inclusion gaps: Organ function is adequate set to No. No exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: No
BMI over 30: Yes"
ASCE_0079,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: No
BMI over 30: No"
ASCE_0080,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: No
BMI over 30: Yes"
ASCE_0081,ASCENT-05,Eligible,Eligible despite minor inclusion gaps: ECOG performance status is 0 or 1 set to No. No exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0082,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0083,ASCENT-05,Eligible,Eligible despite minor inclusion gaps: Has received radiotherapy set to No. No exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0084,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0085,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0086,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0087,ASCENT-05,Eligible,"Eligible despite minor inclusion gaps: Patient is over 18, ECOG performance status is 0 or 1 set to No. No exclusion criteria violated.","Patient is over 18: No
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0088,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: No
BMI over 30: No"
ASCE_0089,ASCENT-05,Eligible,Eligible despite minor inclusion gaps: Organ function is adequate set to No. No exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: No
BMI over 30: No"
ASCE_0090,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0091,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0092,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0093,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0094,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: No"
ASCE_0095,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: No
BMI over 30: No"
ASCE_0096,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0097,ASCENT-05,Eligible,Eligible despite minor inclusion gaps: ECOG performance status is 0 or 1 set to No. No exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: No
BMI over 30: No"
ASCE_0098,ASCENT-05,Eligible,Eligible despite minor inclusion gaps: Has received radiotherapy set to No. No exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: No
BMI over 30: Yes"
ASCE_0099,ASCENT-05,Eligible,Eligible: all required inclusion criteria mostly satisfied and no exclusion criteria violated.,"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: No"
ASCE_0100,ASCENT-05,Eligible,Eligible despite minor inclusion gaps: Patient is over 18 set to No. No exclusion criteria violated.,"Patient is over 18: No
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: No
BMI over 30: Yes"
ASCE_0101,ASCENT-05,Not Eligible,"Not eligible due to: Has distant metastasis is Yes (violates exclusion), Has cardiac condition is Yes (violates exclusion), Has active infection is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: Yes
Has history of cancer: No
Has cardiac condition: Yes
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: Yes
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: No
BMI over 30: Yes"
ASCE_0102,ASCENT-05,Not Eligible,"Not eligible due to: Has distant metastasis is Yes (violates exclusion), Has history of cancer is Yes (violates exclusion), Has cardiac condition is Yes (violates exclusion), Is pregnant or breastfeeding is Yes (violates exclusion), Has arrhythmia is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: No
Organ function is adequate: No
Has received radiotherapy: No
Has distant metastasis: Yes
Has history of cancer: Yes
Has cardiac condition: Yes
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: Yes
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: Yes
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: No
BMI over 30: Yes"
ASCE_0103,ASCENT-05,Not Eligible,"Not eligible due to: Has history of cancer is Yes (violates exclusion), Has cardiac condition is Yes (violates exclusion), Has active infection is Yes (violates exclusion), Has arrhythmia is Yes (violates exclusion), Previously treated with CD137 agent is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: Yes
Has cardiac condition: Yes
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: Yes
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: Yes
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: Yes
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: Yes
HER2 negative: No
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0104,ASCENT-05,Not Eligible,"Not eligible due to: Has distant metastasis is Yes (violates exclusion), Has history of cancer is Yes (violates exclusion), Has cardiac condition is Yes (violates exclusion), Left ventricular ejection fraction is below 50% is Yes (violates exclusion), Previously treated with CD137 agent is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: No
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: Yes
Has history of cancer: Yes
Has cardiac condition: Yes
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: Yes
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: Yes
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: No
BMI over 30: Yes"
ASCE_0105,ASCENT-05,Not Eligible,"Not eligible due to: Has cardiac condition is Yes (violates exclusion), Has received HER2-targeted therapy before is Yes (violates exclusion), Is pregnant or breastfeeding is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: No
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: Yes
Has BRCA mutation: No
Has received HER2-targeted therapy before: Yes
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: Yes
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0106,ASCENT-05,Not Eligible,"Not eligible due to: Has distant metastasis is Yes (violates exclusion), Has received HER2-targeted therapy before is Yes (violates exclusion), Is pregnant or breastfeeding is Yes (violates exclusion), Left ventricular ejection fraction is below 50% is Yes (violates exclusion), Has arrhythmia is Yes (violates exclusion), Previously treated with CD137 agent is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: No
Has distant metastasis: Yes
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: Yes
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: Yes
Left ventricular ejection fraction is below 50%: Yes
Has arrhythmia: Yes
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: Yes
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: Yes
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: No
Family history of cancer: No
BMI over 30: No"
ASCE_0107,ASCENT-05,Not Eligible,"Not eligible due to: Has history of cancer is Yes (violates exclusion), Has received HER2-targeted therapy before is Yes (violates exclusion), Has received endocrine therapy before is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: Yes
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: Yes
Has received endocrine therapy before: Yes
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: Yes
Progesterone receptor positive: Yes
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0108,ASCENT-05,Not Eligible,"Not eligible due to: Has active infection is Yes (violates exclusion), Previously treated with CTLA-4 inhibitor is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: Yes
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: Yes
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: No
HER2 negative: No
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0109,ASCENT-05,Not Eligible,"Not eligible due to: Has history of cancer is Yes (violates exclusion), Left ventricular ejection fraction is below 50% is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: Yes
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: Yes
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0110,ASCENT-05,Not Eligible,"Not eligible due to: Has received HER2-targeted therapy before is Yes (violates exclusion), Has received endocrine therapy before is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: Yes
Has received endocrine therapy before: Yes
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: Yes
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: No
BMI over 30: No"
ASCE_0111,ASCENT-05,Not Eligible,"Not eligible due to: Left ventricular ejection fraction is below 50% is Yes (violates exclusion), Previously treated with CD137 agent is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: Yes
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: Yes
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: No
BMI over 30: Yes"
ASCE_0112,ASCENT-05,Not Eligible,"Not eligible due to: Left ventricular ejection fraction is below 50% is Yes (violates exclusion), Previously treated with CD137 agent is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: Yes
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: Yes
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: No
BMI over 30: No"
ASCE_0113,ASCENT-05,Not Eligible,"Not eligible due to: Has received endocrine therapy before is Yes (violates exclusion), Has active infection is Yes (violates exclusion), Previously treated with CD137 agent is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: Yes
Has active infection: Yes
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: Yes
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: No
BMI over 30: No"
ASCE_0114,ASCENT-05,Not Eligible,"Not eligible due to: Has cardiac condition is Yes (violates exclusion), Is pregnant or breastfeeding is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: Yes
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: Yes
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: Yes
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0115,ASCENT-05,Not Eligible,"Not eligible due to: Has BRCA mutation is Yes (violates exclusion), Has received HER2-targeted therapy before is Yes (violates exclusion), Has active infection is Yes (violates exclusion), Has arrhythmia is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: Yes
Has received HER2-targeted therapy before: Yes
Has received endocrine therapy before: No
Has active infection: Yes
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: Yes
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0116,ASCENT-05,Not Eligible,"Not eligible due to: Has cardiac condition is Yes (violates exclusion), Has arrhythmia is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: Yes
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: Yes
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: Yes
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0117,ASCENT-05,Not Eligible,"Not eligible due to: Has history of cancer is Yes (violates exclusion), Has BRCA mutation is Yes (violates exclusion), Has received endocrine therapy before is Yes (violates exclusion), Has arrhythmia is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: Yes
Has cardiac condition: No
Has BRCA mutation: Yes
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: Yes
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: Yes
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: No
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: No
BMI over 30: Yes"
ASCE_0118,ASCENT-05,Not Eligible,"Not eligible due to: Has cardiac condition is Yes (violates exclusion), Left ventricular ejection fraction is below 50% is Yes (violates exclusion), Previously treated with CD137 agent is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: Yes
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: Yes
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: Yes
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: Yes
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0119,ASCENT-05,Not Eligible,"Not eligible due to: Has received endocrine therapy before is Yes (violates exclusion), Is pregnant or breastfeeding is Yes (violates exclusion), Left ventricular ejection fraction is below 50% is Yes (violates exclusion), Previously treated with CTLA-4 inhibitor is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: Yes
Has active infection: No
Is pregnant or breastfeeding: Yes
Left ventricular ejection fraction is below 50%: Yes
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: Yes
Previously treated with CD137 agent: No
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: No
Progesterone receptor positive: Yes
HER2 negative: No
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: No
BMI over 30: No"
ASCE_0120,ASCENT-05,Not Eligible,"Not eligible due to: Has distant metastasis is Yes (violates exclusion), Has cardiac condition is Yes (violates exclusion), Has received HER2-targeted therapy before is Yes (violates exclusion), Left ventricular ejection fraction is below 50% is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: Yes
Has history of cancer: No
Has cardiac condition: Yes
Has BRCA mutation: No
Has received HER2-targeted therapy before: Yes
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: Yes
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: No"
ASCE_0121,ASCENT-05,Not Eligible,"Not eligible due to: Has distant metastasis is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: No
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: Yes
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: Yes
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: No
BMI over 30: No"
ASCE_0122,ASCENT-05,Not Eligible,"Not eligible due to: Has history of cancer is Yes (violates exclusion), Is pregnant or breastfeeding is Yes (violates exclusion), Has arrhythmia is Yes (violates exclusion), Previously treated with CD137 agent is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: No
Organ function is adequate: No
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: Yes
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: Yes
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: Yes
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: Yes
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: No
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0123,ASCENT-05,Not Eligible,"Not eligible due to: Has distant metastasis is Yes (violates exclusion), Has active infection is Yes (violates exclusion), Has arrhythmia is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: No
Has distant metastasis: Yes
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: Yes
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: Yes
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: No
Progesterone receptor positive: Yes
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0124,ASCENT-05,Not Eligible,"Not eligible due to: Has received endocrine therapy before is Yes (violates exclusion), Has arrhythmia is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: No
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: Yes
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: Yes
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: Yes
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0125,ASCENT-05,Not Eligible,Not eligible due to: Has distant metastasis is Yes (violates exclusion),"Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: Yes
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: No
BMI over 30: No"
ASCE_0126,ASCENT-05,Not Eligible,"Not eligible due to: Has BRCA mutation is Yes (violates exclusion), Has received HER2-targeted therapy before is Yes (violates exclusion), Has received endocrine therapy before is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: No
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: Yes
Has received HER2-targeted therapy before: Yes
Has received endocrine therapy before: Yes
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0127,ASCENT-05,Not Eligible,"Not eligible due to: Previously treated with OX40 agent is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: Yes
BMI over 30: No"
ASCE_0128,ASCENT-05,Not Eligible,"Not eligible due to: Has distant metastasis is Yes (violates exclusion), Has received HER2-targeted therapy before is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: No
Has distant metastasis: Yes
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: Yes
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: Yes
Progesterone receptor positive: Yes
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0129,ASCENT-05,Not Eligible,"Not eligible due to: Has history of cancer is Yes (violates exclusion), Has cardiac condition is Yes (violates exclusion), Has BRCA mutation is Yes (violates exclusion), Has received endocrine therapy before is Yes (violates exclusion), Left ventricular ejection fraction is below 50% is Yes (violates exclusion), Previously treated with CTLA-4 inhibitor is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: Yes
Has cardiac condition: Yes
Has BRCA mutation: Yes
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: Yes
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: Yes
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: Yes
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: No
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0130,ASCENT-05,Not Eligible,"Not eligible due to: Has received HER2-targeted therapy before is Yes (violates exclusion), Has active infection is Yes (violates exclusion), Is pregnant or breastfeeding is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: No
Organ function is adequate: No
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: Yes
Has received endocrine therapy before: No
Has active infection: Yes
Is pregnant or breastfeeding: Yes
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: No
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0131,ASCENT-05,Not Eligible,"Not eligible due to: Has history of cancer is Yes (violates exclusion), Has cardiac condition is Yes (violates exclusion), Is pregnant or breastfeeding is Yes (violates exclusion), Previously treated with CD137 agent is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: Yes
Has cardiac condition: Yes
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: Yes
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: Yes
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: Yes
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: Yes
BMI over 30: No"
ASCE_0132,ASCENT-05,Not Eligible,"Not eligible due to: Has history of cancer is Yes (violates exclusion), Has active infection is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: Yes
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: Yes
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: Yes
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: No
Family history of cancer: No
BMI over 30: No"
ASCE_0133,ASCENT-05,Not Eligible,"Not eligible due to: Has BRCA mutation is Yes (violates exclusion), Has received HER2-targeted therapy before is Yes (violates exclusion), Previously treated with CD137 agent is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: Yes
Has received HER2-targeted therapy before: Yes
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: Yes
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: Yes
Progesterone receptor positive: No
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0134,ASCENT-05,Not Eligible,"Not eligible due to: Has distant metastasis is Yes (violates exclusion), Has BRCA mutation is Yes (violates exclusion), Left ventricular ejection fraction is below 50% is Yes (violates exclusion), Has arrhythmia is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: Yes
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: Yes
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: Yes
Has arrhythmia: Yes
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: Yes
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0135,ASCENT-05,Not Eligible,"Not eligible due to: Has distant metastasis is Yes (violates exclusion), Has active infection is Yes (violates exclusion), Is pregnant or breastfeeding is Yes (violates exclusion), Has arrhythmia is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: No
Has distant metastasis: Yes
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: Yes
Is pregnant or breastfeeding: Yes
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: Yes
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: Yes
Progesterone receptor positive: Yes
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: No
Family history of cancer: No
BMI over 30: No"
ASCE_0136,ASCENT-05,Not Eligible,"Not eligible due to: Has received HER2-targeted therapy before is Yes (violates exclusion), Previously treated with CTLA-4 inhibitor is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: Yes
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: Yes
Previously treated with CD137 agent: No
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: No
BMI over 30: No"
ASCE_0137,ASCENT-05,Not Eligible,"Not eligible due to: Has distant metastasis is Yes (violates exclusion), Has BRCA mutation is Yes (violates exclusion), Previously treated with CTLA-4 inhibitor is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: Yes
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: Yes
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: Yes
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0138,ASCENT-05,Not Eligible,"Not eligible due to: Has distant metastasis is Yes (violates exclusion), Has BRCA mutation is Yes (violates exclusion), Is pregnant or breastfeeding is Yes (violates exclusion), Previously treated with CTLA-4 inhibitor is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: No
Has distant metastasis: Yes
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: Yes
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: Yes
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: Yes
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: No
BMI over 30: Yes"
ASCE_0139,ASCENT-05,Not Eligible,"Not eligible due to: Has BRCA mutation is Yes (violates exclusion), Has arrhythmia is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: Yes
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: Yes
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: Yes
Progesterone receptor positive: No
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: No
BMI over 30: No"
ASCE_0140,ASCENT-05,Not Eligible,"Not eligible due to: Has distant metastasis is Yes (violates exclusion), Has cardiac condition is Yes (violates exclusion), Has received endocrine therapy before is Yes (violates exclusion), Left ventricular ejection fraction is below 50% is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: Yes
Has history of cancer: No
Has cardiac condition: Yes
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: Yes
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: Yes
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: No
BMI over 30: No"
ASCE_0141,ASCENT-05,Not Eligible,"Not eligible due to: Has received HER2-targeted therapy before is Yes (violates exclusion), Previously treated with CTLA-4 inhibitor is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: Yes
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: Yes
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: Yes
Progesterone receptor positive: Yes
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: No
BMI over 30: No"
ASCE_0142,ASCENT-05,Not Eligible,"Not eligible due to: Has received endocrine therapy before is Yes (violates exclusion), Left ventricular ejection fraction is below 50% is Yes (violates exclusion), Has arrhythmia is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: Yes
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: Yes
Has arrhythmia: Yes
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0143,ASCENT-05,Not Eligible,"Not eligible due to: Has history of cancer is Yes (violates exclusion), Has cardiac condition is Yes (violates exclusion), Has BRCA mutation is Yes (violates exclusion), Has received HER2-targeted therapy before is Yes (violates exclusion), Has active infection is Yes (violates exclusion), Is pregnant or breastfeeding is Yes (violates exclusion), Left ventricular ejection fraction is below 50% is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: Yes
Has cardiac condition: Yes
Has BRCA mutation: Yes
Has received HER2-targeted therapy before: Yes
Has received endocrine therapy before: No
Has active infection: Yes
Is pregnant or breastfeeding: Yes
Left ventricular ejection fraction is below 50%: Yes
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: Yes
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: No
BMI over 30: Yes"
ASCE_0144,ASCENT-05,Not Eligible,"Not eligible due to: Has history of cancer is Yes (violates exclusion), Has active infection is Yes (violates exclusion), Has arrhythmia is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: Yes
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: Yes
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: Yes
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: Yes
Progesterone receptor positive: Yes
HER2 negative: No
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0145,ASCENT-05,Not Eligible,"Not eligible due to: Has distant metastasis is Yes (violates exclusion), Has received endocrine therapy before is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: Yes
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: Yes
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: Yes
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0146,ASCENT-05,Not Eligible,"Not eligible due to: Has history of cancer is Yes (violates exclusion), Has received endocrine therapy before is Yes (violates exclusion), Left ventricular ejection fraction is below 50% is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: Yes
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: Yes
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: Yes
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: Yes
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: No
Family history of cancer: No
BMI over 30: Yes"
ASCE_0147,ASCENT-05,Not Eligible,"Not eligible due to: Has BRCA mutation is Yes (violates exclusion), Previously treated with CD137 agent is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: No
Organ function is adequate: No
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: Yes
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: Yes
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: Yes
HER2 negative: No
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: No
BMI over 30: No"
ASCE_0148,ASCENT-05,Not Eligible,"Not eligible due to: Has cardiac condition is Yes (violates exclusion), Has BRCA mutation is Yes (violates exclusion), Has received HER2-targeted therapy before is Yes (violates exclusion), Has received endocrine therapy before is Yes (violates exclusion), Previously treated with CTLA-4 inhibitor is Yes (violates exclusion), Previously treated with CD137 agent is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: Yes
Has BRCA mutation: Yes
Has received HER2-targeted therapy before: Yes
Has received endocrine therapy before: Yes
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: Yes
Previously treated with CD137 agent: Yes
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: No
HER2 negative: No
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0149,ASCENT-05,Not Eligible,"Not eligible due to: Has BRCA mutation is Yes (violates exclusion), Has active infection is Yes (violates exclusion), Is pregnant or breastfeeding is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: Yes
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: Yes
Is pregnant or breastfeeding: Yes
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: No
HER2 negative: No
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0150,ASCENT-05,Not Eligible,"Not eligible due to: Has distant metastasis is Yes (violates exclusion), Has active infection is Yes (violates exclusion), Has arrhythmia is Yes (violates exclusion), Previously treated with CTLA-4 inhibitor is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: No
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: Yes
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: Yes
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: Yes
Previously treated with CTLA-4 inhibitor: Yes
Previously treated with CD137 agent: No
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: No
HER2 negative: No
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0151,ASCENT-05,Not Eligible,"Not eligible due to: Has history of cancer is Yes (violates exclusion), Has received HER2-targeted therapy before is Yes (violates exclusion), Left ventricular ejection fraction is below 50% is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: Yes
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: Yes
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: Yes
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: Yes
Progesterone receptor positive: No
HER2 negative: No
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0152,ASCENT-05,Not Eligible,"Not eligible due to: Has received HER2-targeted therapy before is Yes (violates exclusion), Has received endocrine therapy before is Yes (violates exclusion), Previously treated with CD137 agent is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: Yes
Has received endocrine therapy before: Yes
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: Yes
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: Yes
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: No
BMI over 30: No"
ASCE_0153,ASCENT-05,Not Eligible,"Not eligible due to: Has distant metastasis is Yes (violates exclusion), Has BRCA mutation is Yes (violates exclusion), Has received endocrine therapy before is Yes (violates exclusion), Left ventricular ejection fraction is below 50% is Yes (violates exclusion), Has arrhythmia is Yes (violates exclusion), Previously treated with CTLA-4 inhibitor is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: No
Has distant metastasis: Yes
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: Yes
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: Yes
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: Yes
Has arrhythmia: Yes
Previously treated with CTLA-4 inhibitor: Yes
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: Yes
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: No
Family history of cancer: No
BMI over 30: No"
ASCE_0154,ASCENT-05,Not Eligible,"Not eligible due to: Has received HER2-targeted therapy before is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: Yes
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: Yes
Progesterone receptor positive: No
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: Yes
BMI over 30: No"
ASCE_0155,ASCENT-05,Not Eligible,"Not eligible due to: Has active infection is Yes (violates exclusion), Is pregnant or breastfeeding is Yes (violates exclusion), Left ventricular ejection fraction is below 50% is Yes (violates exclusion), Previously treated with CD137 agent is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: Yes
Is pregnant or breastfeeding: Yes
Left ventricular ejection fraction is below 50%: Yes
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: Yes
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: Yes
Progesterone receptor positive: Yes
HER2 negative: No
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0156,ASCENT-05,Not Eligible,"Not eligible due to: Has BRCA mutation is Yes (violates exclusion), Is pregnant or breastfeeding is Yes (violates exclusion), Previously treated with CTLA-4 inhibitor is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: Yes
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: Yes
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: Yes
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: No
HER2 negative: No
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0157,ASCENT-05,Not Eligible,"Not eligible due to: Has received endocrine therapy before is Yes (violates exclusion), Left ventricular ejection fraction is below 50% is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: Yes
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: Yes
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: Yes
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: No
BMI over 30: Yes"
ASCE_0158,ASCENT-05,Not Eligible,"Not eligible due to: Has cardiac condition is Yes (violates exclusion), Has active infection is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: Yes
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: Yes
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0159,ASCENT-05,Not Eligible,"Not eligible due to: Has distant metastasis is Yes (violates exclusion), Left ventricular ejection fraction is below 50% is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: No
Has distant metastasis: Yes
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: Yes
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: No
Progesterone receptor positive: Yes
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0160,ASCENT-05,Not Eligible,"Not eligible due to: Has cardiac condition is Yes (violates exclusion), Has received HER2-targeted therapy before is Yes (violates exclusion), Is pregnant or breastfeeding is Yes (violates exclusion), Previously treated with CD137 agent is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: Yes
Has BRCA mutation: No
Has received HER2-targeted therapy before: Yes
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: Yes
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: Yes
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: No
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0161,ASCENT-05,Not Eligible,"Not eligible due to: Has distant metastasis is Yes (violates exclusion), Has arrhythmia is Yes (violates exclusion), Previously treated with CTLA-4 inhibitor is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: Yes
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: Yes
Previously treated with CTLA-4 inhibitor: Yes
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: Yes
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: Yes
BMI over 30: No"
ASCE_0162,ASCENT-05,Not Eligible,"Not eligible due to: Has cardiac condition is Yes (violates exclusion), Has received endocrine therapy before is Yes (violates exclusion), Has arrhythmia is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: Yes
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: Yes
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: Yes
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: Yes
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: No
Family history of cancer: Yes
BMI over 30: No"
ASCE_0163,ASCENT-05,Not Eligible,"Not eligible due to: Has history of cancer is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: Yes
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0164,ASCENT-05,Not Eligible,"Not eligible due to: Has BRCA mutation is Yes (violates exclusion), Has active infection is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: Yes
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: Yes
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: Yes
Progesterone receptor positive: Yes
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: No
BMI over 30: No"
ASCE_0165,ASCENT-05,Not Eligible,"Not eligible due to: Has received HER2-targeted therapy before is Yes (violates exclusion), Previously treated with CTLA-4 inhibitor is Yes (violates exclusion), Previously treated with CD137 agent is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: No
Organ function is adequate: No
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: Yes
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: Yes
Previously treated with CD137 agent: Yes
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: Yes
Progesterone receptor positive: Yes
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: No
BMI over 30: Yes"
ASCE_0166,ASCENT-05,Not Eligible,"Not eligible due to: Has received HER2-targeted therapy before is Yes (violates exclusion), Left ventricular ejection fraction is below 50% is Yes (violates exclusion), Previously treated with CD137 agent is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: Yes
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: Yes
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: Yes
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: Yes
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: No
Family history of cancer: No
BMI over 30: No"
ASCE_0167,ASCENT-05,Not Eligible,"Not eligible due to: Has distant metastasis is Yes (violates exclusion), Previously treated with CD137 agent is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: No
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: Yes
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: Yes
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: Yes
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0168,ASCENT-05,Not Eligible,"Not eligible due to: Has active infection is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: Yes
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: No
Progesterone receptor positive: Yes
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0169,ASCENT-05,Not Eligible,"Not eligible due to: Has history of cancer is Yes (violates exclusion), Has received endocrine therapy before is Yes (violates exclusion), Left ventricular ejection fraction is below 50% is Yes (violates exclusion), Has arrhythmia is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: Yes
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: Yes
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: Yes
Has arrhythmia: Yes
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: No
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0170,ASCENT-05,Not Eligible,"Not eligible due to: Has history of cancer is Yes (violates exclusion), Has cardiac condition is Yes (violates exclusion), Has received endocrine therapy before is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: Yes
Has cardiac condition: Yes
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: Yes
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: Yes
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: Yes
BMI over 30: No"
ASCE_0171,ASCENT-05,Not Eligible,"Not eligible due to: Has history of cancer is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: No
Organ function is adequate: No
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: Yes
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: Yes
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: No
Family history of cancer: Yes
BMI over 30: No"
ASCE_0172,ASCENT-05,Not Eligible,"Not eligible due to: Has history of cancer is Yes (violates exclusion), Previously treated with CTLA-4 inhibitor is Yes (violates exclusion), Previously treated with CD137 agent is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: Yes
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: Yes
Previously treated with CD137 agent: Yes
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: Yes
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: No
BMI over 30: No"
ASCE_0173,ASCENT-05,Not Eligible,"Not eligible due to: Has received HER2-targeted therapy before is Yes (violates exclusion), Previously treated with CD137 agent is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: Yes
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: Yes
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: Yes
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0174,ASCENT-05,Not Eligible,"Not eligible due to: Has received HER2-targeted therapy before is Yes (violates exclusion), Has arrhythmia is Yes (violates exclusion), Previously treated with CTLA-4 inhibitor is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: No
Organ function is adequate: No
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: Yes
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: Yes
Previously treated with CTLA-4 inhibitor: Yes
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: Yes
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: No
Family history of cancer: Yes
BMI over 30: No"
ASCE_0175,ASCENT-05,Not Eligible,"Not eligible due to: Has history of cancer is Yes (violates exclusion), Has cardiac condition is Yes (violates exclusion), Has received endocrine therapy before is Yes (violates exclusion), Has active infection is Yes (violates exclusion), Has arrhythmia is Yes (violates exclusion), Previously treated with CD137 agent is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: Yes
Has cardiac condition: Yes
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: Yes
Has active infection: Yes
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: Yes
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: Yes
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: Yes
Family history of cancer: No
BMI over 30: No"
ASCE_0176,ASCENT-05,Not Eligible,"Not eligible due to: Has cardiac condition is Yes (violates exclusion), Has received HER2-targeted therapy before is Yes (violates exclusion), Has active infection is Yes (violates exclusion), Left ventricular ejection fraction is below 50% is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: No
Organ function is adequate: No
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: Yes
Has BRCA mutation: No
Has received HER2-targeted therapy before: Yes
Has received endocrine therapy before: No
Has active infection: Yes
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: Yes
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: Yes
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: No
Family history of cancer: No
BMI over 30: No"
ASCE_0177,ASCENT-05,Not Eligible,"Not eligible due to: Has BRCA mutation is Yes (violates exclusion), Left ventricular ejection fraction is below 50% is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: Yes
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: Yes
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: No
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: No
BMI over 30: No"
ASCE_0178,ASCENT-05,Not Eligible,"Not eligible due to: Has history of cancer is Yes (violates exclusion), Has BRCA mutation is Yes (violates exclusion), Has received HER2-targeted therapy before is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: Yes
Has cardiac condition: No
Has BRCA mutation: Yes
Has received HER2-targeted therapy before: Yes
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: Yes
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0179,ASCENT-05,Not Eligible,"Not eligible due to: Has received endocrine therapy before is Yes (violates exclusion), Has arrhythmia is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: No
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: Yes
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: Yes
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: Yes
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0180,ASCENT-05,Not Eligible,"Not eligible due to: Has BRCA mutation is Yes (violates exclusion), Has received HER2-targeted therapy before is Yes (violates exclusion), Has received endocrine therapy before is Yes (violates exclusion), Previously treated with CTLA-4 inhibitor is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: Yes
Has received HER2-targeted therapy before: Yes
Has received endocrine therapy before: Yes
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: Yes
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: Yes
Progesterone receptor positive: Yes
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: No
BMI over 30: No"
ASCE_0181,ASCENT-05,Not Eligible,"Not eligible due to: Has BRCA mutation is Yes (violates exclusion), Has received endocrine therapy before is Yes (violates exclusion), Has active infection is Yes (violates exclusion), Left ventricular ejection fraction is below 50% is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: Yes
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: Yes
Has active infection: Yes
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: Yes
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: Yes
Progesterone receptor positive: Yes
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: No
Family history of cancer: Yes
BMI over 30: No"
ASCE_0182,ASCENT-05,Not Eligible,"Not eligible due to: Has history of cancer is Yes (violates exclusion), Has cardiac condition is Yes (violates exclusion), Has BRCA mutation is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: No
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: Yes
Has cardiac condition: Yes
Has BRCA mutation: Yes
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: No
HER2 negative: No
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0183,ASCENT-05,Not Eligible,"Not eligible due to: Has cardiac condition is Yes (violates exclusion), Has active infection is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: No
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: Yes
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: Yes
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: No
BMI over 30: No"
ASCE_0184,ASCENT-05,Not Eligible,"Not eligible due to: Has cardiac condition is Yes (violates exclusion), Left ventricular ejection fraction is below 50% is Yes (violates exclusion), Previously treated with CTLA-4 inhibitor is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: No
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: Yes
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: Yes
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: Yes
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: Yes
Progesterone receptor positive: Yes
HER2 negative: No
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0185,ASCENT-05,Not Eligible,"Not eligible due to: Has cardiac condition is Yes (violates exclusion), Has received endocrine therapy before is Yes (violates exclusion), Has arrhythmia is Yes (violates exclusion), Previously treated with CTLA-4 inhibitor is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: Yes
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: Yes
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: Yes
Previously treated with CTLA-4 inhibitor: Yes
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: Yes
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: Yes
BMI over 30: No"
ASCE_0186,ASCENT-05,Not Eligible,"Not eligible due to: Has distant metastasis is Yes (violates exclusion), Has received HER2-targeted therapy before is Yes (violates exclusion), Previously treated with CD137 agent is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: No
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: Yes
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: Yes
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: Yes
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0187,ASCENT-05,Not Eligible,"Not eligible due to: Has distant metastasis is Yes (violates exclusion), Has BRCA mutation is Yes (violates exclusion), Is pregnant or breastfeeding is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: Yes
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: Yes
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: Yes
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: Yes
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: No
BMI over 30: No"
ASCE_0188,ASCENT-05,Not Eligible,"Not eligible due to: Has distant metastasis is Yes (violates exclusion), Has received HER2-targeted therapy before is Yes (violates exclusion), Has active infection is Yes (violates exclusion), Has arrhythmia is Yes (violates exclusion), Previously treated with CD137 agent is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: Yes
Organ function is adequate: Yes
Has received radiotherapy: No
Has distant metastasis: Yes
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: Yes
Has received endocrine therapy before: No
Has active infection: Yes
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: Yes
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: Yes
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: Yes
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0189,ASCENT-05,Not Eligible,"Not eligible due to: Has cardiac condition is Yes (violates exclusion), Has BRCA mutation is Yes (violates exclusion), Has received HER2-targeted therapy before is Yes (violates exclusion), Has active infection is Yes (violates exclusion), Left ventricular ejection fraction is below 50% is Yes (violates exclusion), Has arrhythmia is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: No
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: Yes
Has BRCA mutation: Yes
Has received HER2-targeted therapy before: Yes
Has received endocrine therapy before: No
Has active infection: Yes
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: Yes
Has arrhythmia: Yes
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: Yes
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: No
BMI over 30: No"
ASCE_0190,ASCENT-05,Not Eligible,"Not eligible due to: Has history of cancer is Yes (violates exclusion), Has received HER2-targeted therapy before is Yes (violates exclusion), Has received endocrine therapy before is Yes (violates exclusion), Has arrhythmia is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: Yes
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: Yes
Has received endocrine therapy before: Yes
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: Yes
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: Yes
Progesterone receptor positive: No
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: No
BMI over 30: No"
ASCE_0191,ASCENT-05,Not Eligible,"Not eligible due to: Has active infection is Yes (violates exclusion), Left ventricular ejection fraction is below 50% is Yes (violates exclusion), Previously treated with CTLA-4 inhibitor is Yes (violates exclusion), Previously treated with CD137 agent is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: No
Organ function is adequate: No
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: Yes
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: Yes
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: Yes
Previously treated with CD137 agent: Yes
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: Yes
HER2 negative: No
Triple negative breast cancer: No
Smoker: Yes
Family history of cancer: No
BMI over 30: No"
ASCE_0192,ASCENT-05,Not Eligible,"Not eligible due to: Has history of cancer is Yes (violates exclusion), Previously treated with CD137 agent is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: No
Organ function is adequate: No
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: Yes
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: Yes
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0193,ASCENT-05,Not Eligible,"Not eligible due to: Has history of cancer is Yes (violates exclusion), Has cardiac condition is Yes (violates exclusion), Has active infection is Yes (violates exclusion), Previously treated with CD137 agent is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: Yes
Has cardiac condition: Yes
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: Yes
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: Yes
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: Yes
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: No
Family history of cancer: No
BMI over 30: No"
ASCE_0194,ASCENT-05,Not Eligible,"Not eligible due to: Has BRCA mutation is Yes (violates exclusion), Has received endocrine therapy before is Yes (violates exclusion), Left ventricular ejection fraction is below 50% is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: No
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: Yes
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: Yes
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: Yes
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: Yes
Progesterone receptor positive: Yes
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: No
BMI over 30: Yes"
ASCE_0195,ASCENT-05,Not Eligible,Not eligible due to: Has BRCA mutation is Yes (violates exclusion),"Patient is over 18: Yes
ECOG performance status is 0 or 1: No
Organ function is adequate: No
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: Yes
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: Yes
Progesterone receptor positive: No
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0196,ASCENT-05,Not Eligible,"Not eligible due to: Has cardiac condition is Yes (violates exclusion), Has active infection is Yes (violates exclusion), Has arrhythmia is Yes (violates exclusion), Previously treated with CTLA-4 inhibitor is Yes (violates exclusion), Previously treated with CD137 agent is Yes (violates exclusion)","Patient is over 18: No
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: No
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: Yes
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: Yes
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: Yes
Previously treated with CTLA-4 inhibitor: Yes
Previously treated with CD137 agent: Yes
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: Yes
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: No
BMI over 30: Yes"
ASCE_0197,ASCENT-05,Not Eligible,"Not eligible due to: Has BRCA mutation is Yes (violates exclusion), Left ventricular ejection fraction is below 50% is Yes (violates exclusion), Previously treated with CD137 agent is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: No
Organ function is adequate: Yes
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: Yes
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: Yes
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: Yes
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: Yes
Triple negative breast cancer: Yes
Smoker: No
Family history of cancer: No
BMI over 30: Yes"
ASCE_0198,ASCENT-05,Not Eligible,"Not eligible due to: Has distant metastasis is Yes (violates exclusion), Previously treated with CD137 agent is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: Yes
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: No
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: Yes
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: Yes
HER2 negative: Yes
Triple negative breast cancer: No
Smoker: No
Family history of cancer: Yes
BMI over 30: No"
ASCE_0199,ASCENT-05,Not Eligible,"Not eligible due to: Has cardiac condition is Yes (violates exclusion), Has received HER2-targeted therapy before is Yes (violates exclusion), Has received endocrine therapy before is Yes (violates exclusion), Has active infection is Yes (violates exclusion), Has arrhythmia is Yes (violates exclusion), Previously treated with topoisomerase inhibitor is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: Yes
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: No
Has history of cancer: No
Has cardiac condition: Yes
Has BRCA mutation: No
Has received HER2-targeted therapy before: Yes
Has received endocrine therapy before: Yes
Has active infection: Yes
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: Yes
Previously treated with CTLA-4 inhibitor: No
Previously treated with CD137 agent: No
Previously treated with OX40 agent: No
Previously treated with topoisomerase inhibitor: Yes
Estrogen receptor positive: Yes
Progesterone receptor positive: No
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: Yes
BMI over 30: Yes"
ASCE_0200,ASCENT-05,Not Eligible,"Not eligible due to: Has distant metastasis is Yes (violates exclusion), Has received HER2-targeted therapy before is Yes (violates exclusion), Previously treated with CTLA-4 inhibitor is Yes (violates exclusion), Previously treated with OX40 agent is Yes (violates exclusion)","Patient is over 18: Yes
ECOG performance status is 0 or 1: No
Organ function is adequate: No
Has received radiotherapy: Yes
Has distant metastasis: Yes
Has history of cancer: No
Has cardiac condition: No
Has BRCA mutation: No
Has received HER2-targeted therapy before: Yes
Has received endocrine therapy before: No
Has active infection: No
Is pregnant or breastfeeding: No
Left ventricular ejection fraction is below 50%: No
Has arrhythmia: No
Previously treated with CTLA-4 inhibitor: Yes
Previously treated with CD137 agent: No
Previously treated with OX40 agent: Yes
Previously treated with topoisomerase inhibitor: No
Estrogen receptor positive: No
Progesterone receptor positive: No
HER2 negative: No
Triple negative breast cancer: No
Smoker: No
Family history of cancer: No
BMI over 30: Yes"
